Iekuni Oh
Tochigi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults.
Journal: Leukemia research
Published: March 31, 2023
Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose.
Journal: Internal medicine (Tokyo, Japan)
Published: January 13, 2022
NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia.
Journal: International journal of hematology
Published: December 19, 2021
Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion Cohort.
Journal: Acta haematologica
Published: July 20, 2021
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Journal: Asia-Pacific journal of clinical oncology
Published: March 19, 2021
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Journal: Blood advances
Published: January 18, 2021
Risk factors for high-dose methotrexate-induced nephrotoxicity.
Journal: International journal of hematology
Published: October 15, 2020
Clinical association between thyroid disease and immune thrombocytopenia.
Journal: Annals of hematology
Published: July 27, 2020
Ultrasonography and fine needle aspiration cytology of thyroid Langerhans cell histiocytosis lesions.
Journal: Journal of medical ultrasonics (2001)
Published: July 11, 2020
Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.
Journal: PloS one
Published: June 20, 2020
Steep neutrophil recovery following unrelated bone marrow transplantation is a major risk factor for the development of acute graft-vs-host disease-a retrospective study.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: June 14, 2020
Last Updated: 09/26/2026